Growth Metrics

Ironwood Pharmaceuticals (IRWD) Amortization of Deferred Charges (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Amortization of Deferred Charges for 13 consecutive years, with $418000.0 as the latest value for Q4 2025.

  • Quarterly Amortization of Deferred Charges rose 0.72% to $418000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, down 12.39% year-over-year, with the annual reading at $1.7 million for FY2025, 12.39% down from the prior year.
  • Amortization of Deferred Charges hit $418000.0 in Q4 2025 for Ironwood Pharmaceuticals, roughly flat from $418000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $6.1 million in Q4 2021 to a low of $350000.0 in Q3 2024.
  • Historically, Amortization of Deferred Charges has averaged $1.6 million across 5 years, with a median of $500500.0 in 2022.
  • Biggest five-year swings in Amortization of Deferred Charges: tumbled 93.49% in 2022 and later soared 46.75% in 2023.
  • Year by year, Amortization of Deferred Charges stood at $6.1 million in 2021, then crashed by 93.49% to $400000.0 in 2022, then skyrocketed by 46.75% to $587000.0 in 2023, then dropped by 29.3% to $415000.0 in 2024, then grew by 0.72% to $418000.0 in 2025.
  • Business Quant data shows Amortization of Deferred Charges for IRWD at $418000.0 in Q4 2025, $418000.0 in Q3 2025, and $416000.0 in Q2 2025.